Research Article Open Access

POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE

Vidyanand Rabi Das1, Dharmendra Singh1, Krishna Murti2, Sushmita Das1, Pradeep Das1 and Krishna Pandey3
  • 1 Rajendra Memorial Research Institute of Medical Sciences, India
  • 2 National Institute of Pharmacy and Education Research, India
  • 3 Rajendra Memorial Research Institute of Medical Sciences , India

Abstract

Visceral Leishmaniasis (VL) or Kala-Azar (KA) is highly endemic in the Indian subcontinent particularly in Bihar. Post Kala-azar Dermal Leishmaniasis (PKDL) is a known reservoir for leishmania parasites for transmission of VL. The kala-azar elimination program was launched by the government of three countries of the Indian subcontinent in the year 2005, which aims to eliminate kala-azar by 2015 and PKDL by 2018. PKDL diagnosis and management has not been addressed properly. In this case report we have described a case of PKDL with ulcer and atypical presentation who was subsequently diagnosed by demonstration of Leishmania donovani bodies in the skin snips through microscopy, kinetoplast-DNA nested PCR and clinically. The patient was treated with miltefosine capsules in the dose of 50 mg twice-a-day for twelve-weeks and responded completely. This case report assumes great importance as prompt diagnosis and treatment of PKDL is essential in the kala-azar elimination program.

American Journal of Infectious Diseases
Volume 10 No. 2, 2014, 50-55

DOI: https://doi.org/10.3844/ajidsp.2014.50.55

Submitted On: 28 February 2014 Published On: 2 April 2014

How to Cite: Das, V. R., Singh, D., Murti, K., Das, S., Das, P. & Pandey, K. (2014). POST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE. American Journal of Infectious Diseases, 10(2), 50-55. https://doi.org/10.3844/ajidsp.2014.50.55

  • 4,172 Views
  • 2,765 Downloads
  • 9 Citations

Download

Keywords

  • PKDL
  • VL
  • Miltefosine
  • Ulcer
  • Kala-Azar Elimination Program